TWi Biotechnology, Inc. (TPEX:6610)
Taiwan · Delayed Price · Currency is TWD 35.05
-1.20 (-3.31%)
Oct 31, 2025, 2:57 PM CST
TWi Biotechnology Market Cap
TWi Biotechnology has a market cap or net worth of 3.77 billion as of October 31, 2025. Its market cap has increased by 220.00% in one year.
Market Cap
3.77B
Enterprise Value
3.44B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
35.05
Market Cap Chart
Since December 27, 2016, TWi Biotechnology's market cap has decreased from 3.83B to 3.77B, a decrease of -1.45%. That is a compound annual growth rate of -0.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 3.77B | 208.53% |
| Dec 31, 2024 | 1.22B | -0.52% |
| Dec 29, 2023 | 1.23B | 22.02% |
| Dec 30, 2022 | 1.01B | -7.50% |
| Dec 30, 2021 | 1.09B | 7.31% |
| Dec 31, 2020 | 1.01B | 72.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |